S1219 A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With Inflammatory Bowel DiSease Therapy: Updates From the ASSIST Study
Jordan E. Axelrad(New York University), Raymond Cross(University of Maryland, Baltimore), Chelsea Anderson(University of North Carolina at Chapel Hill), Millie D. Long(University of North Carolina Health Care), Anita Afzali(University of Cincinnati Medical Center), Sara N. Horst, Abigail R. Noyes(University of Maryland, Baltimore), Kara DeFelice(University of Cincinnati Medical Center), Tamar Sapir
Cited by 0
Related Papers
ACG Clinical Guideline: Ulcerative Colitis in Adults
|The American Journal of Gastroenterology|2019|1.6k
Acute engagement of Gq-mediated signaling in the bed nucleus of the stria terminalis induces anxiety-like behavior
|Molecular Psychiatry|2016|97
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2024
|Gastroenterology|2025|97
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
|The Lancet. Gastroenterology & hepatology|2021|96
Prevalence and Costs of Eosinophilic Esophagitis in the United States
|Clinical Gastroenterology and Hepatology|2024|94